Loading data for SGP — first visit, this takes a few seconds.
SpyGlass Pharma Inc. (SGP)
NasdaqGS: SGP
· Real-Time Price · USD
26.51
+0.28 (1.07%)
At close: Aug 24, 2026, 6:44 PM
The price, the headline numbers and the latest news, in one place.
SpyGlass Pharma Inc. (SGP) Stock Price, Analysis & Data
1.07% (1D)
No data available
| Bid | 19.01 |
| Market Cap | 879.51M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -56.05M |
| n/a | |
| -1.68 | |
| n/a | |
| -9.68 | |
| P/B (ttm) | 3.51 |
| P/S (ttm) | n/a |
| Earnings Date | Nov 5, 2026 |
| Ask | 33.93 |
| Volume | 51,474 |
| Avg. Volume (20D) | 114,588 |
| Open | 26.55 |
| Previous Close | 26.23 |
| Day's Range | 26.27 - 27.44 |
| 52-Week Range | 17.06 - 32.44 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SGP
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 6, 2026
Employees 76
Stock Exchange NasdaqGS
Ticker Symbol SGP
Website https://www.spyglasspharma.com
Financial Performance
In 2025, SpyGlass Pharma's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -39.87M, an increase of 36.71%.
Financial StatementsEarnings Surprise
SpyGlass Pharma has released their quarterly earnings on Aug 6, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.59 misses estimates by -0.04, with -Infinity% YoY decline.
SpyGlass Pharma Inc. is scheduled to release its earnings on Nov 5, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
